Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concerta for Smoking Prevention in ADHD Youth
NCT00181714Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Nov 2003
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Massachusetts General Hospital. Primary endpoint: Cigarette Smoking Rates at 24 months. Started Nov 2003; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00181714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00181714.